Peter Kolchinsky
Boston, Massachusetts, United States
10K followers
500+ connections
Activity
-
On Aug 1, Jnana was acquired by Otsuka for $800m (+milestones). The story of how PKU became the first killer app for Jnana’s SLC discovery platform…
On Aug 1, Jnana was acquired by Otsuka for $800m (+milestones). The story of how PKU became the first killer app for Jnana’s SLC discovery platform…
Liked by Peter Kolchinsky
-
An outstanding 5 years of Nucleate. Check out our first Impact Report! https://lnkd.in/gD7NPP3K I’m proud of the work we’ve accomplished, and…
An outstanding 5 years of Nucleate. Check out our first Impact Report! https://lnkd.in/gD7NPP3K I’m proud of the work we’ve accomplished, and…
Liked by Peter Kolchinsky
-
A thought on impact on investing of price control talks, patent waivers, North Korean small pox, and an alien invasion. Peter Kolchinsky's comment…
A thought on impact on investing of price control talks, patent waivers, North Korean small pox, and an alien invasion. Peter Kolchinsky's comment…
Shared by Peter Kolchinsky
Experience
-
RA Capital Management, LP
-
-
-
-
Education
-
Harvard University
-
Publications
-
The Great American Drug Deal
Evelexa Press
America is rightfully outraged when patients can’t afford the medicines they need. The drug industry stands accused of charging too much. Many proposed solutions, including drug price controls, threaten to defund innovation but also distract the public from the real problem, which lies in the unraveling of the biotech social contract – the implicit agreement between the biopharmaceutical industry and American society. The role of insurance and the value of what should be a celebrated national…
America is rightfully outraged when patients can’t afford the medicines they need. The drug industry stands accused of charging too much. Many proposed solutions, including drug price controls, threaten to defund innovation but also distract the public from the real problem, which lies in the unraveling of the biotech social contract – the implicit agreement between the biopharmaceutical industry and American society. The role of insurance and the value of what should be a celebrated national resource - the growing mountain of generic drugs - are overlooked and yet form the foundation of a workable solution.
The Great American Drug Deal examines the healthcare landscape through the lens of this contract, including the government's role in inventing drugs, direct-to-consumer advertising, the opioid crisis, the price-jacking of old drugs, and the impact on America of lower drug costs in other countries. Most importantly, this book describes concrete, actionable reforms under which patients will be able to afford their treatments and society will continue to reap the benefits of medical innovation. -
The Biotech Social Contract
Medium
This series of articles aims to define the biopharmaceutical industry’s social contract with America, to examine practices that deviate from that contract, and to propose refinements to healthcare policy to ensure that our continued investment in scientific progress ultimately yields affordable, effective therapeutics for future generations.
More activity by Peter
-
On National Patient Advocacy Day, we’re reminded of the critical role patients must play in making the system work. It’s a day that shouldn’t need to…
On National Patient Advocacy Day, we’re reminded of the critical role patients must play in making the system work. It’s a day that shouldn’t need to…
Liked by Peter Kolchinsky
-
First Fierce, now Stat… the “price controls are actually fine for innovation” argument sure seems irresistibly contagious. In this case, STAT…
First Fierce, now Stat… the “price controls are actually fine for innovation” argument sure seems irresistibly contagious. In this case, STAT…
Shared by Peter Kolchinsky
-
It was an honor and pleasure to be involved in these conversations with the IQT (In-Q-Tel) team. Many of the same markets and technology areas…
It was an honor and pleasure to be involved in these conversations with the IQT (In-Q-Tel) team. Many of the same markets and technology areas…
Liked by Peter Kolchinsky
-
𝐀𝐧𝐨𝐭𝐡𝐞𝐫 $0.02 𝐨𝐧 𝐈𝐑𝐀 𝐌𝐅𝐏𝐬 & 𝐭𝐡𝐞 𝐩𝐨𝐥𝐢𝐭𝐢𝐜𝐚𝐥 𝐬𝐩𝐢𝐧 So, we finally got our first look at the “maximum fair prices” (MFPs)…
𝐀𝐧𝐨𝐭𝐡𝐞𝐫 $0.02 𝐨𝐧 𝐈𝐑𝐀 𝐌𝐅𝐏𝐬 & 𝐭𝐡𝐞 𝐩𝐨𝐥𝐢𝐭𝐢𝐜𝐚𝐥 𝐬𝐩𝐢𝐧 So, we finally got our first look at the “maximum fair prices” (MFPs)…
Liked by Peter Kolchinsky
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More